Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1971 Apr;8(4):593–602.

Two-colour immunofluorescence studies on EBV-determined antigens

G Klein, L Gergely, G Goldstein
PMCID: PMC1712959  PMID: 4325123

Abstract

Two-colour fluorescence (TRITC and FITC) has been adapted for the direct visualization of Epstein-Barr virus (EBV)-determined membrane antigens (MA) and to study their relationship to genetically determined iso-antigens (HL-A type) and to viral capsid antigens (VCA, as defined by the Henle test). The following three postulates, based on indirect deductions from previous blocking, cross-blocking and absorption experiments, could be confirmed by direct visual observation:

(1) Membrane receptors of the HL-A and of the EBV determined MA type are distinct with regard to localization and antigenic specificity;

(2) Different subcomponents within the MA complex are part of the same macromolecular structure on the outer cell membrane;

(3) VCA and MA antigens are distinct with regard to specificity.

In addition, it has been shown that all VCA positive cells are also MA positive in EBV-carrier cultures, but that there exists, in such cultures, a 10-fold excess of MA positive, VCA negative cells.

Full text

PDF
593

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki T., Boyse E. A., Old L. J., De Harven E., Hämmerling U., Wood H. A. G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A. 1970 Mar;65(3):569–576. doi: 10.1073/pnas.65.3.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boyse E. A., Old L. J., Stockert E. An approach to the mapping of antigens on the cell surface. Proc Natl Acad Sci U S A. 1968 Jul;60(3):886–893. doi: 10.1073/pnas.60.3.886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bremberg S., Klein G., Epstein A. Direct membrane fluorescence reaction of EBV-carrying human lymphoblastoid cells: blocking tests with xenogeneic antisera. Int J Cancer. 1969 Nov 15;4(6):761–766. doi: 10.1002/ijc.2910040603. [DOI] [PubMed] [Google Scholar]
  4. Dunkel V. C., Zeigel R. F. Studies on the relation of membrane immunofluorescence to Epstein-Barr virus infection. J Natl Cancer Inst. 1970 Jan;44(1):133–144. [PubMed] [Google Scholar]
  5. Goldstein G., Klein G., Pearson G., Clifford P. Direct membrane immunofluorescence reaction of Burkitt's lymphoma cells in culture. Cancer Res. 1969 Apr;29(4):749–752. [PubMed] [Google Scholar]
  6. Gunvén P., Klein G., Henle G., Henle W., Clifford P. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients. Nature. 1970 Dec 12;228(5276):1053–1056. doi: 10.1038/2281053a0. [DOI] [PubMed] [Google Scholar]
  7. Henle G., Henle W., Clifford P., Diehl V., Kafuko G. W., Kirya B. G., Klein G., Morrow R. H., Munube G. M., Pike P. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst. 1969 Nov;43(5):1147–1157. [PubMed] [Google Scholar]
  8. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968 Jan;59(1):94–101. doi: 10.1073/pnas.59.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Henle W., Henle G., Ho H. C., Burtin P., Cachin Y., Clifford P., de Schryver A., de-Thé G., Diehl V., Klein G. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst. 1970 Jan;44(1):225–231. [PubMed] [Google Scholar]
  11. Henle W., Henle G., Zajac B. A., Pearson G., Waubke R., Scriba M. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science. 1970 Jul 10;169(3941):188–190. doi: 10.1126/science.169.3941.188. [DOI] [PubMed] [Google Scholar]
  12. Johansson B., Klein G., Henle W., Henle G. Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease. Int J Cancer. 1970 Nov 15;6(3):450–462. doi: 10.1002/ijc.2910060316. [DOI] [PubMed] [Google Scholar]
  13. Klein G., Clifford P., Klein E., Smith R. T., Minowada J., Kourilsky F. M., Burchenal J. H. Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures. J Natl Cancer Inst. 1967 Nov;39(5):1027–1044. [PubMed] [Google Scholar]
  14. Klein G., Geering G., Old L. J., Henle G., Henle W., Clifford P. Comparison of the anti-EBV titer and the EBV-associated membrane reactive and precipitating antibody levels in the sera of Burkitt lymphoma and nasopharyngeal carcinoma patients and controls. Int J Cancer. 1970 Mar 15;5(2):185–194. doi: 10.1002/ijc.2910050204. [DOI] [PubMed] [Google Scholar]
  15. Klein G., Pearson G., Henle G., Henle W., Goldstein G., Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. 3. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera. J Exp Med. 1969 Apr 1;129(4):697–705. doi: 10.1084/jem.129.4.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Klein G., Pearson G., Nadkarni J. S., Nadkarni J. J., Klein E., Henle G., Henle W., Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med. 1968 Nov 1;128(5):1011–1020. doi: 10.1084/jem.128.5.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kristofová H., Lengerová A., Rejzková J. Indirect mapping of spatial distribution of some H-2 antigens on the cell membrane. Folia Biol (Praha) 1970;16(2):81–88. [PubMed] [Google Scholar]
  18. Pearson G., Klein G., Henle G., Henle W., Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence. J Exp Med. 1969 Apr 1;129(4):707–718. doi: 10.1084/jem.129.4.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Svedmyr A., Demissie A., Klein G., Clifford P. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus. J Natl Cancer Inst. 1970 Mar;44(3):595–610. [PubMed] [Google Scholar]
  20. Yata J., Klein G., Hewetson J., Gergely L. Effect of metabolic inhibitors on membrane immunofluorescence reactivity of established Burkitt lymphoma cell lines. Int J Cancer. 1970 May 15;5(3):394–403. doi: 10.1002/ijc.2910050314. [DOI] [PubMed] [Google Scholar]
  21. Yata J., Klein G. Some factors affecting membrane immunofluorescence reactivity of Burkitt lymphoma tissue culture cell lines. Int J Cancer. 1969 Nov 15;4(6):767–775. doi: 10.1002/ijc.2910040604. [DOI] [PubMed] [Google Scholar]
  22. de Schryver A., Friberg S., Jr, Klein G., Henle W., Henle G., De-Thé G., Clifford P., Ho H. C. Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space. Clin Exp Immunol. 1969 Nov;5(5):443–459. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES